Home | Welcome to Contract Pharma   
Last Updated Wednesday, April 16 2014
Print

Topics - Regulatory Affairs


Refine by Date:
From: To:
By Gil Roth
Published February 26, 2014
Exchange of ideas can lead to mutually beneficial linkages Read More »
By Gil Roth
Published February 12, 2014
Focuses on three themes, streamlines informatics offerings Read More »
By Gil Roth
Published February 11, 2014
Biannual event attracts scientists, executives Read More »
By Gil Roth
Published February 5, 2014
First-year goals met Read More »
By Andrew Badrot, CMS Pharma
Published January 30, 2014
DSM & Patheon unlock value through a creative merger Read More »
By Gil Roth
Published January 15, 2014
AbbVie, Antares, Elite, Galectin, La Jolla Read More »
By Gil Roth
Published January 15, 2014
Otrexup approved in October 2013 for RA, pJIA Read More »
By Gil Roth
Published January 15, 2014
Camargo conducts abuse-deterrence study under 505(b)2 Read More »
By Gil Roth
Published January 14, 2014
FDA recognizes need for dabrafenib treatment Read More »
By Gil Roth
Published January 13, 2014
Ampio, Galectin, Generex, Gilead, Merck, The Medicines Company Read More »
By Gil Roth
Published January 13, 2014
Ampion to test against OAK Read More »
By Gil Roth
Published January 13, 2014
Carbavance entering Ph II in 2014 Read More »
By Gil Roth
Published January 13, 2014
Filing covers advanced melanoma, expected to be complete in 1H14 Read More »
By Gil Roth
Published January 13, 2014
Idelalisib has Breakthrough designation for CLL Read More »
By Gil Roth
Published January 10, 2014
Mannkind's inhaleable insulin to get committee review Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On